McVey D S, Loan R W, Purdy C W, Richards A E
Department of Veterinary Microbiology and Parasitology, Texas A&M University, College Station 77843.
Am J Vet Res. 1989 Apr;50(4):443-7.
Serum samples obtained from feeder calves before and after entry into the market system (days 0 to 7) were assayed for antibodies to Pasteurella hamolytica biotype A, serotype 1 capsular polysaccharide (CPS) and lipopolysaccharide/outer membrane protein (LPSp) by isotype in a kinetic-augmented, antigen-capture ELISA. These test results, plus indirect hemagglutination (IHA) antibody titers, and hemolysin-in-gel test (HIGT) findings were compared with clinical performance data during the initial 4 weeks in the feedlot (receiving period). High concentrations of HIGT antibody, at the point of initial assembly of feeder calves at weaning and during the subsequent 7-day marketing period, were associated with freedom from bovine respiratory disease (BRD) during the receiving period. High or rapidly increasing concentrations of anti-CPS IgG1 during the marketing period were also associated with less BRD. However, high concentrations of anti-LPSp IgG1 during the marketing period were associated with increased BRD during the receiving period. There was no correlation between the concentrations of antibody determined by IHA tests early in the marketing period and freedom from BRD during the receiving period. High concentrations of antibody determined by this test at entry into the feedlot (day 7) were associated with a high incidence of BRD. Calves vaccinated with a P haemolytica bacterin had significantly (P less than 0.05) higher HIGT values and concentrations of anti-LPSp IgG1 and IHA antibody than did nonvaccinated calves on entry into the feedlot (day 7). Vaccination appeared to have little effect on the amount of anti-CPS IgG1. Of all the tests used to quantitate antibody, the HIGT correlated best with clinical performance.(ABSTRACT TRUNCATED AT 250 WORDS)
在进入市场系统前后(第0至7天)从育肥牛犊采集血清样本,通过动力学增强抗原捕获酶联免疫吸附测定法(ELISA),按同种型检测针对溶血巴斯德氏菌生物型A、1型血清型荚膜多糖(CPS)和脂多糖/外膜蛋白(LPSp)的抗体。将这些检测结果,加上间接血凝(IHA)抗体效价和凝胶溶血素试验(HIGT)结果,与育肥场最初4周(接收期)的临床表现数据进行比较。在断奶时育肥牛犊初次组群时以及随后7天的销售期内,高浓度的HIGT抗体与接收期内无牛呼吸道疾病(BRD)相关。销售期内抗CPS IgG1浓度高或快速升高也与较少的BRD相关。然而,销售期内高浓度的抗LPSp IgG1与接收期内BRD增加相关。销售期早期通过IHA试验测定的抗体浓度与接收期内无BRD之间无相关性。进入育肥场(第7天)时通过该试验测定的高浓度抗体与BRD的高发病率相关。与进入育肥场(第7天)时未接种疫苗的牛犊相比,接种溶血巴斯德氏菌菌苗的牛犊的HIGT值、抗LPSp IgG1和IHA抗体浓度显著更高(P小于0.05)。接种疫苗似乎对抗CPS IgG1的量影响不大。在所有用于定量抗体的试验中,HIGT与临床表现的相关性最佳。(摘要截短于250字)